MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer

Predictive Factor ◽

Pathologic Response ◽

Complete Pathologic Response

Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer

PLoS ONE ◽

10.1371/journal.pone.0207224 ◽

2018 ◽

Vol 13 (11) ◽

pp. e0207224 ◽

Cited By ~ 12

Author(s):

Javier Cuello-López ◽

Ana Fidalgo-Zapata ◽

Laura López-Agudelo ◽

Elsa Vásquez-Trespalacios

Keyword(s):

Breast Cancer ◽

Predictive Factor ◽

Pathologic Response ◽

Response To Neoadjuvant Chemotherapy

Platelet To Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB)

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05599-1 ◽

2020 ◽

Vol 181 (2) ◽

pp. 249-254 ◽

Cited By ~ 2

Author(s):

Kathriena Greenwell ◽

Lala Hussain ◽

David Lee ◽

Matthew Bramlage ◽

Gordon Bills ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Pathologic Response ◽

National Cancer Database ◽

Pathologic Response Rate

Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-3304 ◽

2015 ◽

Vol 22 (1) ◽

pp. 26-33 ◽

Cited By ~ 24

Author(s):

Christos Hatzis ◽

W. Fraser Symmans ◽

Ya Zhang ◽

Rebekah E. Gould ◽

Stacy L. Moulder ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathologic Response ◽

Response To Neoadjuvant Chemotherapy

Survivin As a Predictive Biomarker of Complete Pathologic Response to Neoadjuvant Chemotherapy in Patients With Stage II and Stage III Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.03.002 ◽

2011 ◽

Vol 11 (2) ◽

pp. 129-134 ◽

Cited By ~ 18

Author(s):

Cristiane Rios Petrarca ◽

Andre T. Brunetto ◽

Vinicius Duval ◽

Adriana Brondani ◽

Gisele Pereira Carvalho ◽

...

Keyword(s):

Breast Cancer ◽

Predictive Biomarker ◽

Pathologic Response ◽

Stage Ii ◽

Stage Iii ◽

Response To Neoadjuvant Chemotherapy

Stage Iii Breast Cancer ◽

A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05889-8 ◽

2020 ◽

Vol 184 (3) ◽

pp. 861-872

Author(s):

Sarah Nietz ◽

Daniel S O’Neil ◽

Oluwatosin Ayeni ◽

Wenlong Carl Chen ◽

Maureen Joffe ◽

...

Keyword(s):

Breast Cancer ◽

Hiv Infection ◽

Cancer Patients ◽

South African ◽

Response Rates ◽

Pathologic Response ◽

Breast Cancer Patients

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03981705 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Pathologic Response ◽

Complete Pathologic Response

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

Annals of Surgical Oncology ◽

10.1245/s10434-011-1877-y ◽

2011 ◽

Vol 19 (1) ◽

pp. 253-258 ◽

Cited By ~ 28

Author(s):

Carla S. Fisher ◽

Cynthia X. Ma ◽

William E. Gillanders ◽

Rebecca L. Aft ◽

Timothy J. Eberlein ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathologic Response ◽

Complete Pathologic Response

Abstract PD3-04: Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2 ratio in HER2 over-expressing breast cancer: Analysis of the National cancer database (NCDB)

10.1158/1538-7445.sabcs17-pd3-04 ◽

2018 ◽

Author(s):

K Greenwell ◽

L Hussain ◽

C Ho ◽

E Dunki-Jacobs ◽

D Lee ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Pathologic Response ◽

National Cancer Database ◽

Pathologic Response Rate

Ki-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

10.26226/morressier.599bdc7ad462b80296ca087f ◽

2017 ◽

Author(s):

Nejc Kozar

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Predictive Factor ◽

Breast Cancer Patients ◽

Ki 67

70P “Early tumor shrinkage” might be a novel predictive factor relating to pCR in neoadjuvant chemotherapy for resectable breast cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00230-1 ◽

2016 ◽

Vol 27 ◽

pp. ix21

Author(s):

T. Saiki ◽

A. Ishiguro ◽

Y. Tabata ◽

H. Kato ◽

Y. Narita

Keyword(s):

Breast Cancer ◽

Predictive Factor ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Early Tumor